Elanco Animal Health Incorporated (ELAN)
NYSE: ELAN · IEX Real-Time Price · USD
14.01
-0.09 (-0.64%)
At close: Jul 2, 2024, 4:00 PM
14.03
+0.02 (0.14%)
After-hours: Jul 2, 2024, 7:07 PM EDT

Elanco Animal Health Revenue

Elanco Animal Health had revenue of $4.37B in the twelve months ending March 31, 2024, down -1.76% year-over-year. Revenue in the quarter ending March 31, 2024 was $1.21B, a -4.14% decrease year-over-year. In the year 2023, Elanco Animal Health had annual revenue of $4.42B with 0.14% growth.

Revenue (ttm)
$4.37B
Revenue Growth
-1.76%
P/S Ratio
1.59
Revenue / Employee
$445,408
Employees
9,800
Market Cap
6.92B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20234.42B6.00M0.14%
Dec 31, 20224.41B-353.00M-7.41%
Dec 31, 20214.76B1.49B45.64%
Dec 31, 20203.27B200.00M6.51%
Dec 31, 20193.07B4.20M0.14%
Dec 31, 20183.07B177.80M6.15%
Dec 31, 20172.89B-24.50M-0.84%
Dec 31, 20162.91B4.40M0.15%
Dec 31, 20152.91B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Ensign Group 3.85B
Jazz Pharmaceuticals 3.84B
Bio-Rad Laboratories 2.61B
Penumbra 1.10B
HealthEquity 1.04B
Ionis Pharmaceuticals 776.62M
Repligen 607.45M
Intra-Cellular Therapies 513.93M
Revenue Rankings